As we wait on our purity/dosage test results hopefully arriving on Wednesday, and Sterility a few weeks after, I think people should consider some things about all this burning:
- Amo has been POPULAR the last month or so, more incidences of bad stuff happening is bound to happen in some amount. I'm not saying this is above that normal amount, but some IS expected in my opinion.
- About 3.3% (1 in 30) of patients on prescription Mounjaro during the phase 3 study experienced injection site reactions and went away on their own, which was considered NORMAL. I have not seen any reports of burning/stinging and it not going away (please respond if you are having a long lasting reaction, as I would be very interested).
- Negativity bias, Selection bias and inverse survivorship bias- This is the tendency for us to focus on BAD outcomes, and the tendency for people who have BAD experiences to speak up (as they should), but that also skews statistical reality.
So here is what I did to prove a point with this stuff, I went since page 15 of this thread to now to count how many individuals had experiences with T specifically, and what their reactions were:
11 users reported without stinging
1 user reported stinging but with amazon reconstitution water
1 user reported stinging and sick but it was first experience with tirz and they got better over time
4 users reported burning (seemed like a genuine case)
The rate of people who report bad vs. good outcomes is a little hard to pin down, but most sources state it's at a rate of 2:1 to 3:1. Let's just use the 2:1 to give the worst possible scenario, and perform some math. For simplicity's sake I'm going to assume all negative reviews were AmoPure's fault:
11 users reported good, 6 users reported bad
If we take 2:1 ratio of bad to good reports, then we get (11*2) : (6*1)
22 "theoretical" good outcomes for each 6 bad reports, this comes out to a negative % on product of 21.4%.
Keep in mind this is using the WORST possible view of this data, I would imagine if we were betting, I would aim for more like 10-15% negative product experiences.
Knowing that 3.3% bad experience is NORMAL per phase 3 trials, we can assume there is an ELEVATED risk of bad experience, but not some huge kind of outbreak here.
Moral of the story: I would bet there is probably a 10% increase in burning occurrence in Amo's Tirz vs. prescription Mounjaro, color me (pikachu surprised face) that a grey market vendor has a slightly elevated rate of issues vs. a ~1 trillion dollar company.
Having seen the data and approached my own safety risk, I'll initially be buying some filtered syringes to address any possible contamination issues, and buy some pH strips for my own personal stash.